PAS-19-317 - Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) is used for the submission of applications to the following Notices of Special Interest (NOSIs)
Active NOSIs
| Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
| Notice of Correction to Award Project Period Information for PAS-19-317, "Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R41/R42 Clinical Trial Optional) |
NOT-AG-22-012 |
NIA, NINDS |
Jan 24, 2022 |
Apr 15, 2026 |
R41/R42 |
Expired NOSIs
| Title |
Notice Number |
Organization |
Release Date |
Expiration Date |
Activity Code(s) |
| Notice of Special Interest (NOSI): Validation of Digital Health and Artificial Intelligence Tools for Improved Assessment in Epidemiological, Clinical, and Intervention Research |
NOT-CA-22-037 |
NCI, NHLBI, NIA, NIDA, NIMH, NINR, OBSSR |
Jan 27, 2022 |
Mar 9, 2024 |
R01, R03, R21, R43/R44, R41/R42, R33, R34, R61/R33 |
| Notice of Special Interest (NOSI): Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health |
NOT-OD-21-100 |
OBSSR, NIMHD, NIDA, NIMH, ORWH, NIDCD, SGMRO, ODP, NIA, NHLBI, NCI, NINR, NCCIH, NEI, NICHD |
Apr 8, 2021 |
Jun 8, 2024 |
R01, R21, R03, R41/R42, R43/R44, R21/R33, UG3/UH3, R34 |
An official website of the United States government
